ADARx Pharmaceuticals, Inc. (ADRX)

Last Closing Price: 14.00 (2026-11-16)

Shareholders Equity (Annual)

Shareholders Equity: The sum of preferred and common equity items.

ADARx Pharmaceuticals, Inc. (ADRX) had Shareholders Equity of $155.37M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$3.45M
$-73.09M
--
$3.45M
$91.81M
$-88.36M
$15.28M
$-73.09M
$-73.09M
$-73.09M
$-73.09M
$-73.09M
$-73.09M
$-88.36M
$-88.93M
9.70M
9.70M
$-7.54
$-7.54
Balance Sheet Financials
$493.38M
$4.73M
$14.28M
$507.65M
$30.48M
--
$321.80M
$352.29M
$-202.25M
$155.37M
Shareholders Equity
$155.37M
9.66M
Cash Flow Statement Financials
$262.29M
$-209.93M
$0.10M
$14.03M
$66.52M
$52.48M
$6.13M
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--